Found 0 matching trials
A Study of Secukinumab for the Treatment of Alopecia Areata PHASE2 Alopecia areata is a medical condition, in which the hair falls out in patc...
Show More Location
Icahn School of Medicine at Mount Sinai
Learn More & Join Trial
A Phase 2b Study of the Efficacy, Safety, and Tolerability of M1095 (Sonelokimab) in Subjects With Moderate to Severe Psoriasis PHASE2 This is a multi-center phase 2b study in subjects with moderate to severe c...
Show More Location
Investigative Site
Learn More & Join Trial
Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa. N/A The purpose of this observational, prospective, non-interventional, multice...
Show More Status
Active Not Recruiting
Location
Novartis Investigative Site
Learn More & Join Trial
Immunoclassification of Psoriasis: a Strategy for Precision Medicine NA Through the combination of clinical manifestations and omics, the investiga...
Show More Location
2nd Affiliated Hospital, School of Medicine, Zhejiang University
Learn More & Join Trial
Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo PHASE4 To demonstrate that the efficacy of secukinumab 300 mg at Week 16 was super...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis PHASE3 The purpose of this study was to assess the clinical efficacy, safety and t...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A Study of Early Secukinumab Treatment in Moderate to Severe Hidradenitis Suppurativa Patients N/A The aim of this study is to evaluate the effectiveness of early treatment w...
Show More Location
Multiple Locations
Learn More & Join Trial
Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA) PHASE3 This was a double-blind, placebo-controlled, event-driven randomized withdr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Study of Safety, Efficacy and Tolerability of Secukinumab Versus Placebo, in Combination With SoC Therapy, in Patients With Active Lupus Nephritis PHASE3 This was a pivotal, randomized, double-blind, placebo-controlled trial eval...
Show More Location
University Of Alabama
Learn More & Join Trial
A Placebo-controlled Phase 2 Trial to Investigate the Safety and Efficacy of Secukinumab in Giant Cell Arteritis PHASE2 This study was designed to evaluate the efficacy and safety of secukinumab ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial